Should patients with acute lymphoblastic leukemia receive hematopoietic stem-cell transplant from an unrelated donor?

Nat Clin Pract Oncol. 2005 Jan;2(1):18-9. doi: 10.1038/ncponc0060.

Author

Stephen J Forman¹

Affiliation

¹ Division of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA. [email protected]

PMID: 16264849
DOI: 10.1038/ncponc0060

No abstract available

MeSH terms

Adolescent
Adult
Antineoplastic Agents, Alkylating / administration & dosage
Busulfan / administration & dosage
Cyclophosphamide / administration & dosage
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation*
Humans
Male
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
Prognosis
Retrospective Studies
Risk Factors
Transplantation, Autologous
Treatment Outcome
Whole-Body Irradiation

Substances

Antineoplastic Agents, Alkylating
Cyclophosphamide
Busulfan